Monocyte chemoattractant protein-1 (MCP-1), acting through its C-C chemokine receptor 2 (CCR-2), has important roles in inflammation, angiogenesis, and wound repair. The individual and combined effects of inhaled nitric oxide (NO) and hyperoxia on lung MCP-1 and CCR-2 in relation to lung leukocyte dynamics are unknown. Because MCP-1 gene is up-regulated by oxidants, we hypothesized that inhaled NO with hyperoxia will increase MCP-1 production and CCR-2 expression more than either gas alone. We randomly assigned young piglets to breathe room air (RA), RAϩ50 ppm NO (RAϩNO), O 2 , or O 2 ϩNO for 1 or 5 d before sacrifice. Lungs were lavaged and tissues preserved for hybridization studies, Western blotting, histology, and immunohistochemistry. The results show that lung MCP-1 production and alveolar macrophage count were significantly elevated in the 5-d O 2 and O 2 ϩNO groups relative to the RA group (p Յ 0.05). In contrast, lung CCR-2 abundance was diminished in the O 2 group (p Յ 0.05), but not in the O 2 ϩNO group, compared with the RA group. No difference was detected in any variable studied at 24 h. CCR-2 distribution was similar in all groups with staining of alveolar septa, macrophages, vascular endothelium, and the luminal epithelial surface of airways. We conclude that although hyperoxia increases MCP-1 in young piglet lungs, it also decreases CCR-2 abundance, which may limit participation of MCP-1 in alveolar macrophage recruitment. Inhaled NO, unlike hyperoxia, has no significant independent effect, but its concurrent administration during hyperoxia attenuates the decremental effect of hyperoxia on CCR-2 abundance. Abbreviations MCP-1, monocyte chemoattractant protein-1 NO, nitric oxide MPO, myeloperoxidase CCR-2, C-C chemokine receptor 2 RA, room air RPA, ribonuclease protection assay Animals exposed to prolonged hyperoxia suffer lung injury from pulmonary sequestration of activated leukocytes, which release cytokines, reactive oxygen species, and tissuedegrading enzymes (1-3). The leukocyte influx is orchestrated and amplified by chemotactic factors (1-4).In the early phase, neutrophil accumulation predominates, but this pattern changes to one of monocytes/macrophages beyond 72 h (3). The change in the inflammatory cell composition results from proliferation of resident alveolar macrophages as well as pulmonary transmicrovascular migration of blood monocytes (1, 3). The factors controlling these later events are not fully understood, but known proinflammatory cytokines may be involved.MCP-1 is a C-C chemokine with activating and chemoattractant actions on monocytes and macrophages (5). In addition to its chemoattractant characteristics, MCP-1 also induces mesothelial, fibroblast, endothelial, and vascular smooth muscle cell proliferation and migration (6 -9). MCP-1 is produced by various immune and nonimmune cell types including alveolar macrophages (5).The actions of MCP-1 are mediated primarily through CCR-2 (10). These receptors are now known to be expressed by mesothelial, fibroblasts, and endothel...